Skip to content

A real-world study on the preventive effect of acupuncture combined with moxibustion therapy on high-risk patients with ovarian hyperstimulation syndrome (OHSS)

A real-world study on the preventive effect of acupuncture combined with moxibustion therapy on high-risk patients with ovarian hyperstimulation syndrome (OHSS) undergoing IVF

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400094422
Enrollment
Unknown
Registered
2024-12-23
Start date
2025-01-01
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ovarian hyperstimulation syndrome

Interventions

Acupuncture+moxibustion with conventional treatment group (Acupuncture therapy+moxibustion therapy,with conventional treatment):None
conventional treatment group (conventional treatment):None

Sponsors

Chengdu Jinjiang District Maternal and Child Health Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
22 Years to 35 Years

Inclusion criteria

Inclusion criteria: 1 Meets the diagnostic criteria for high risk OHSS in the above line; 2 22 years = age = 35 years, female; 3 Patients who meet the IVF-ET indications and use an antagonist regimen for IVF/ICSI; 4 No acupuncture and moxibustion treatment for IVF-ET or other ongoing clinical researchers in recent 3 months; 5 The informed consent form is signed by the patient themselves or signed by their immediate family members. Note: Only patients who meet the above 5 criteria can be included in this study

Exclusion criteria

Exclusion criteria: 1 Patients with severe systemic organic lesions such as heart, liver, kidney, or endocrine or metabolic disorders; 2 Individuals who suffer from serious mental illnesses, acute infections of the urinary and reproductive systems, or sexually transmitted diseases on either side of the gender; 3 Participants in other clinical trials; 4 Those who do not cooperate with treatment observers. Note: Patients who meet any of the above criteria should be excluded

Design outcomes

Primary

MeasureTime frame
Rate of moderate and severe ovarian hyperstimulation syndrome;

Secondary

MeasureTime frame
biochemical pregnancy;clinical pregnancy;early abortion rate;

Countries

China

Contacts

Public ContactYang Hongmei

Chengdu Jinjiang District Maternal and Child Health Hospital

446716068@qq.com+86 136 4802 6364

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026